| Size & multiples | |||
| Market Cap | $1.46B | Enterprise Value | — |
| P/E (TTM) | 50.02× | PEG (trailing) | 0.89× |
| P/S | 1.43× | P/FCF | 28.78× |
| EV/EBITDA | — | EV/EBIT | — |
| EV/Sales | — | EV/FCF | — |
| FCF Yield | 3.48% | Buyback Yield | — |
| Owner Earnings (TTM) | $30.3M | Owner Earnings Yield | 2.08% |
| Shareholder Yield | — | ||
| Cost of capital & EVAmethodology → | |||
| Beta (5y monthly) | 1.25 | Risk-free (assumed) | 4.00% |
| Equity risk premium (assumed) | 5.00% | Cost of Equity | 10.23% |
| After-tax Cost of Debt | 3.72% | Synthetic credit rating | A |
| Cost of Debt · embedded (pre-tax) | 5.03% | Cost of Debt · marginal (synthetic) | 4.78% |
| WACC | 9.56% | ROIC | — |
| EVA Spread (ROIC−WACC) | — | EVA | — |
FCF runs above owner earnings — under-maintenance or a working-capital release is flattering current cash.
Synthetic rating = ICR-based credit-quality read (Damodaran), not an agency rating.
Flows TTM (last 4 quarters); latest annual for: EPS (Diluted) · EPS TTM $0.84 · revenue TTM $1.02B · FCF TTM $50.8M
Output of a disclosed model whose assumptions may be wrong — research information, not investment advice. See the Disclaimer.
Rich vs Health Care on P/E
P/E 83rd percentile in the Health Care pool — placement read per multiple; the API emits no single blended figure, so none is shown.
Compared against all 1054 Health Care names we cover — one sector-wide pool, so the median skews toward smaller (often unprofitable) companies. Try the Size band for a cap-matched read.
| Metric | This (FY) | Peer median | IQR (25–75) | %ile |
|---|---|---|---|---|
| P/E | 50.0x | 24.4x | 13.0x–39.3x | 83 ↑rich |
| FCF Yield | 2.5% | -7.8% | -34.7%–1.4% | 78 ↑strong |
| Dividend Yield | 0.0% | 1.1% | 0.2%–2.4% | 10 ↓weak |
| Net Margin | 3.1% | -21.2% | -325.3%–7.2% | 68 ↑strong |
| Operating Margin | 5.5% | -34.5% | -552.0%–8.0% | 72 ↑strong |
